Wissenschaftliche Arbeiten

Prof. Dr. Meral Günaldı

147 Publikationen. Neben jeder Publikation steht die Quelle der Angabe.

Zurück zum Profil
  1. Gunaldi, M., Helvaci, A., Demirel Yildirim, N., Aydin, D., & Kara, N. (2011). Multiple myeloma with serous membrane involvement and increased CA-125 and CA 15-3. *Journal of BUON, 16*(4), 778.

    Quelle: Profilseite auf livhospital.com

  2. Usul Afsar, C., Sahin, B., Gunaldi, M., Kılıc Bagir, E., Gumurdulu, D., Burgut, R., Erkisi, M., Kara, I. O., Paydas, S., Karaca, F., & Ercolak, V. (2015). Expression of fibroblast growth factor receptor 1, fibroblast growth factor 2, phosphatidyl inositol 3 phosphate kinase and their clinical and prognostic significance in squamous cell carcinoma of the lung. *International Journal of Clinical and Experimental Pathology, 8*(9), 9760–9771.

    Quelle: Profilseite auf livhospital.com

  3. Kocoglu, H., Dogan, H., Oguz, B., Ocak Serin, S., Okuturlar, Y., Gunaldi, M., Erismis, B., Ozdemir, B., Tural, D., Hursitoglu, M., Harmankaya, O., & Kumbasar, A. (2016). Comparison of survival rates, tumor stages, and localization in obese and nonobese patients with gastric cancer. *Gastroenterology Research and Practice, 2016,* 9382750. https://doi.org/10.1155/2016/9382750

    Quelle: Profilseite auf livhospital.com

  4. Deger, C., Telli, F., Gunaldi, M., Keskin, S., Saglam, S., Ozdemir, O., Sar, C., Parali, E., Erdal, E., Sumer, F., Ozel, O., & Asan, S. (2015). The lifetime cost-of-disease (CoD) of metastatic colorectal cancer (mCRC) in Turkey: An expert panel approach for estimation of costs. *Value in Health, 18*(7), A448.

    Quelle: Profilseite auf livhospital.com

  5. Deger, C., Telli, F., Gunaldi, M., Keskin, S., Saglam, S., Ozdemir, O., Sar, C., Parali, E., Erdal, E., Sumer, F., Ozel, O., & Asan, S. (2015). The cost-of-disease of metastatic/inoperable gastrointestinal stromal tumors in Turkey: An expert panel approach for estimation of costs. *Value in Health, 18*(7), A449.

    Quelle: Profilseite auf livhospital.com

  6. Demir, A., Molinas Mandel, N., Paydas, S., Demir, G., Er, O., Turhal, N. S., Bavbek, S., Eralp, Y., Saip, P. M., Güler, E. N., Aydıner, A., Uluç, B. O., Kılıçkap, S., Üskent, N., Karadurmuş, N., Kaplan, M. A., Yanmaz, M. T., Demir, H., Alan, O., Korkmaz, T., Olgun, P., Uysal, Ö. S., Altundağ, K., Gündüz, Ş., Günaldı, M., Sarı, M., Beypınar, İ., & Başaran, G. (2020). [Article title unavailable]. *Balkan Medical Journal, 37*(2), 104–107. https://doi.org/10.4274/balkanmedj.galenos.2020.2020.2.3

    Quelle: Profilseite auf livhospital.com

  7. Gunaldi, M., Sahin, B., & Tatlı, U. (2011). Osteonecrosis of the jaw in cancer patients treated with bisphosphonates [Poster presentation]. Mediterranean Multidisciplinary Oncology Forum Congress.

    Quelle: Profilseite auf livhospital.com

  8. Tiken, E. E., Günaldı, M., Okuturlar, Y., & Tuna, S. (2014, September 30–October 2). The evaluation of synchronous bilateral breast cancer patients [Poster presentation]. International Breast Cancer Conference, Istanbul, Turkey.

    Quelle: Profilseite auf livhospital.com

  9. Okuturlar, Y., Günaldı, M., Tiken, E. E., Tuna, S., Oztosun, B., Inan, Y., Ercan, T., Harmankaya, O., & Kumbasar, B. (2014, September 30–October 2). Evaluation of body mass index in breast cancer patients [Poster presentation]. International Breast Cancer Conference, Istanbul, Turkey.

    Quelle: Profilseite auf livhospital.com

  10. Günaldı, M., Tiken, E. E., Okuturlar, Y., Tuna, S., & Kapan, S. (2014, September 30–October 2). Neoadjuvant chemotherapy in breast cancer patients: Single centre experience [Poster presentation]. International Breast Cancer Conference, Istanbul, Turkey.

    Quelle: Profilseite auf livhospital.com

  11. Helvaci, A., Çorbacıoğlu, E., & Günaldı, M. (2010, April 15–18). Acute coronary syndrome and its relation with diabetes mellitus and antidiabetic drug [Poster presentation]. 59th ESCVS International Congress in conjunction with the 6th Congress of Update in Cardiology and Cardiovascular Surgery, Cesme, Izmir, Turkey.

    Quelle: Profilseite auf livhospital.com

  12. Okuturlar, Y., Gedikbasi, A., Akalin, N., Gunaldi, M., Yilmaz, D., Karakaya, P., Mert, M., & Harmankaya, O. (2014, June 22–26). Effects of iron therapy on paraoxonase and arylesterase activities in patients with iron deficiency anemia [Poster presentation]. IFCC WorldLab Istanbul 2014, 22nd International Congress of Clinical Chemistry and Laboratory Medicine, Istanbul, Turkey.

    Quelle: Profilseite auf livhospital.com

  13. Afsar, C. U., Gunaldi, M., Okuturlar, Y., Gedikbaşı, A., & Kural, A. (2014). Paraoxonase and arylesterase activities in patients with colorectal cancer [Poster presentation]. Advances in Predictive & Personalized Medicine.

    Quelle: Profilseite auf livhospital.com

  14. Gunaldi, M., Afsar, C. U., Okuturlar, Y., Gedikbaşı, A., Kural, A., & Tiken, E. E. (2014). Can heat shock protein 70 be a target therapy in breast cancer? [Poster presentation]. Advances in Predictive & Personalized Medicine.

    Quelle: Profilseite auf livhospital.com

  15. Okuturlar, Y., Gunaldi, M., Gedikbaşı, A., Kural, A., & Acarer, D. (2014). Breast cancer and paraoxonase activity [Poster presentation]. Advances in Predictive & Personalized Medicine.

    Quelle: Profilseite auf livhospital.com

  16. Isıksacan, N., Koşer, M., Gunaldi, M., & Ördekçi, S. (2014). C-reactive protein (CRP) measurement using point of care (POC) devices [Poster presentation]. Advances in Predictive & Personalized Medicine.

    Quelle: Profilseite auf livhospital.com

  17. Abbasoğlu, D., Gunaldi, M., Sivas, H., Yakıcıer, M. C., & Hızel, H. C. (2014). The factors affecting UGT1A1 enzyme activity of irinotecan drug response in Turkish population [Poster presentation]. 7th Santorini Conference on Systems Personalized Health and Therapy.

    Quelle: Profilseite auf livhospital.com

  18. Günaldı, M., Tiken, E. E., Okuturlar, Y., Tuna, S., & Kapan, S. (2014). Neoadjuvant chemotherapy in breast cancer patients: Single centre experience [Poster presentation]. International Breast Cancer Conference, Istanbul, Turkey.

    Quelle: Profilseite auf livhospital.com

  19. Okuturlar, Y., Tiken, E. E., Tuna, S., Oztosun, B., Inan, Y., Ercan, T., Harmankaya, O., & Kumbasar, B. (2014). Evaluation of body mass index in breast cancer patients [Poster presentation]. International Breast Cancer Conference, Istanbul, Turkey.

    Quelle: Profilseite auf livhospital.com

  20. Günaldı, M., Gürgenyataği, D., Göksu, S., Gülenay, Ş., Yildirim, M., Tiken, E., Okuturlar, Y., & Kahraman, S. (2014). A factor that predicts occurrence of metastasis on stomach cancer patients: PDW [Poster presentation]. 4th International Gastrointestinal Cancer Conference.

    Quelle: Profilseite auf livhospital.com

  21. Okuturlar, Y., Günaldı, M., Gedikbaşı, A., Kural, A., & Acarer, D. (2015). Breast cancer and paraoxonase activity [Poster presentation]. Cancer International Symposium on Advances in Predictive & Personalized Medicine.

    Quelle: Profilseite auf livhospital.com

  22. Gunaldi, M., Okuturlar, Y., Kural, A., Akarsu, C., Karabulut, M., & Gedikbasi, A. (2015, September 6–9). Clinical importance of S100A9 and S100A12 in breast cancer [Poster presentation]. 4th European Congress of Immunology, Vienna, Austria.

    Quelle: Profilseite auf livhospital.com

  23. Gunaldi, M., Isıksacan, N., Okuturlar, Y., Kocoglu, H., & Gunaldi, O. (2015, September 6–9). Clinical significance of serum survivin in cancer patients [Poster presentation]. 4th European Congress of Immunology, Vienna, Austria.

    Quelle: Profilseite auf livhospital.com

  24. Yıldırım, Y., Günaldı, M., & Karaarslan, S. (2013). Kemoterapötik ve moleküler hedefe yönelik tedavide sınıflama, kullanım ve toksisite. In H. Onat (Ed.), Kanser kemoterapi el kitabı. Çukurova Nobel Kitabevi.

    Quelle: Profilseite auf livhospital.com

  25. Günaldı, Ö., & Günaldı, M. (2014). Ommaya rezervuarı. In Nöroşirurjide şant cerrahisi. Selen Yayıncılık.

    Quelle: Profilseite auf livhospital.com

  26. Günaldı, M. (2022, Şubat). Gastrointestinal sistem kanserlerinde güncel yaklaşımlar – Metastatik iyi farklılaşmış gastrointestinal ve pankreas nöroendokrin tümörlerde tedavi.

    Quelle: Profilseite auf livhospital.com

  27. Günaldi, M., Duman, B. B., Erçolak, V., Afşar, Ç. U., Kara, İ. O., & Şahin, B. (2012). Sorafenib ilişkili üç farklı deri toksisitesi: Olgu sunumu. Turkish Journal of Dermatology.

    Quelle: Profilseite auf livhospital.com

  28. Yılmaz, G., Adaş, M., Helvacı, A., Altıntaş, N., & Günaldi, M. (2013). Evaluation of respiratory functions in subclinical and clinical hypothyroidism. Journal of Turgut Ozal Medical Center.

    Quelle: Profilseite auf livhospital.com

  29. Günaldi, M., Duman, B. B., Afşar, Ç. U., Günaldı, Ö., & Şahin, B. (2014). Temporal kemik yerleşimli langerhans hücreli histiositozis: Bir olgu sunumu. Göztepe Tıp Dergisi.

    Quelle: Profilseite auf livhospital.com

  30. Günaldi, M., & Köksal Erkiş, M. (2014). Glioblastome multiformede kemoterapi. Klinik Tıp Bilimleri.

    Quelle: Profilseite auf livhospital.com

  31. Gözkaman, A., Okuturlar, Y., Kanat, Ö., Günaldi, M., Serin, S. O., Saydaroğlu, Ö., Kumbasar, A., & Evrensel, T. (2015). Küçük hücreli akciğer kanserli hastalarda C-Kit (CD117) ekspresyonu. Haseki Tıp Bülteni, 53, 67–71. https://doi.org/10.4274/haseki.2078

    Quelle: Profilseite auf livhospital.com

  32. Okuturlar, Y., Günaldi, M., Tiken, E. E., Tuna, S., Öztosun, B., Özdeminan, Y., Ercan, T., Harmankaya, Ö., & Kumbasar, A. (2015). Fazla kilo ve obezitenin meme kanseri alt tipleri üzerine etkisi. Journal of Clinical and Analytical Medicine.

    Quelle: Profilseite auf livhospital.com

  33. Tiken, E. E., Günaldi, M., Okuturlar, Y., & Tuna, S. (2015). Senkron bilateral meme kanserli hastaların değerlendirilmesi. Istanbul Medical Journal. Advance online publication.

    Quelle: Profilseite auf livhospital.com

  34. Günaldi, M., Duman, B. B., Erçolak, V., Afşar, Ç. U., Paydaş, S., Köksal Erkiş, M., Kara, İ. O., Şahin, B., & Gönlüsen, G. (2014). Osteosarkomların retrospektif değerlendirmesi. Journal of Clinical and Analytical Medicine.

    Quelle: Profilseite auf livhospital.com

  35. Günaldi, M. (2014). Meme kanseri risk faktörleri. Klinik Tıp Aile Hekimliği Dergisi.

    Quelle: Profilseite auf livhospital.com

  36. Özkara, İ. Ö., & Günaldi, M. (2014). Mide kanseri: Önleme, risk faktörleri ve prognoz. Klinik Tıp Aile Hekimliği Dergisi.

    Quelle: Profilseite auf livhospital.com

  37. Günaldı, M., Duman, B. B., Erçolak, V., Afşar, Ç. U., Paydaş, S., Kara, İ. O., Erkişi, M., & Şahin, B. (2012, March 21–25). Trastuzumab ilişkili kardiyotoksisiteye epirubisin ve doksorubisinin katkısının araştırılması [Poster presentation]. 4. Tıbbi Onkoloji Kongresi, Antalya, Turkey.

    Quelle: Profilseite auf livhospital.com

  38. Günaldı, M., Paydaş, S., Afşar, Ç. U., Erçolak, V., Duman, B. B., & Doran, F. (2012, March 21–25). Tuberoskleroz ve malign melanom birlikteliği [Poster presentation]. 4. Tıbbi Onkoloji Kongresi, Antalya, Turkey.

    Quelle: Profilseite auf livhospital.com

  39. Günaldı, M. (2012, March 21–25). Bilateral over metastazı ile tanı konan primer appendiks adenokarsinomu [Poster presentation]. 4. Tıbbi Onkoloji Kongresi, Antalya, Turkey.

    Quelle: Profilseite auf livhospital.com

  40. Günaldı, M., Erkişi, M., Afşar, Ç. U., Duman, B. B., & Erçolak, V. (2012, March 21–25). Richter sendromu [Poster presentation]. 4. Tıbbi Onkoloji Kongresi, Antalya, Turkey.

    Quelle: Profilseite auf livhospital.com

  41. Duman, B. B., Afşar, Ç. U., Günaldı, M., Erkişi, M., Kara, İ. O., Şahin, B., & Kum, P. (2013, April 19–23). Meme kanserli hastalarda adjuvan/neoadjuvan kemoterapi deneyimimiz [Poster presentation]. 20. Ulusal Kanser Kongresi, Antalya, Turkey.

    Quelle: Profilseite auf livhospital.com

  42. Günaldı, M., Kara, İ. O., Afşar, Ç. U., Erçolak, V., & Duman, B. B. (2012, March 21–25). Akromegaliye eşlik eden malign mezankimal tümör [Poster presentation]. 4. Tıbbi Onkoloji Kongresi, Antalya, Turkey.

    Quelle: Profilseite auf livhospital.com

  43. Erçolak, V., Paydaş, S., Şeydaoğlu, G., Günaldı, M., Afşar, Ç. U., & Duman, B. B. (2013). Hodgkin lenfoma olgularında retrospektif değerlendirme [Poster presentation]. 5. Tıbbi Onkoloji Kongresi, Antalya, Turkey.

    Quelle: Profilseite auf livhospital.com

  44. Gunaldi, M., Okuturlar, Y., & Tiken, E. E. (2014, September). Geriatrik meme kanseri hastalarında moleküler alt grup değerlendirmesi [Poster presentation]. 1. Geriatri Onkoloji Kongresi, Antalya, Turkey.

    Quelle: Profilseite auf livhospital.com

  45. Günaldı, M., Erkişi, M., Afşar, Ç. U., Duman, B. B., & Erçolak, V. (2012, March 21–25). Akciğer adenokarsinomlu hastada alfa-2 globulin piki [Poster presentation]. 4. Tıbbi Onkoloji Kongresi, Antalya, Turkey.

    Quelle: Profilseite auf livhospital.com

  46. Duman, B. B., Şahin, B., Erkişi, M., Paydaş, S., Kara, İ. O., Afşar, Ç. U., Günaldı, M., Erçolak, V., & Kum, P. (2012, March 21–25). Metastatik renal hücreli karsinomda sitoredüktif nefrektominin sağkalım üzerine etkisi [Poster presentation]. 4. Tıbbi Onkoloji Kongresi, Antalya, Turkey.

    Quelle: Profilseite auf livhospital.com

  47. Günaldı, M., Şahin, B., Duman, B. B., Erçolak, V., & Afşar, Ç. U. (2012, March 21–25). Bevacizumab çene osteonekrozu için bir risk faktörü müdür? [Poster presentation]. 4. Tıbbi Onkoloji Kongresi, Antalya, Turkey.

    Quelle: Profilseite auf livhospital.com